Skip to main content

WCG Clinical, Inc. (WCGC)

WCG Clinical was planning to go public, but the IPO has been withdrawn.
Stock Price: $15.00 - $17.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading on Invalid Date.
Market Cap6.05B
Revenue (ttm)497.58M
Net Income (ttm)-85.81M
Shares Out378.26M
EPS (ttm)-0.23
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Price Targetn/a
Earnings Daten/a

About WCGC

WCG Clinical is a leading provider of clinical trial solutions, focused on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance. Our transformational solutions enable biopharmaceutical companies, contract research organizations (“CROs”), and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human protection. Our proprietary suite of technology-enabled solutions provides ...

IndustryBiological Research
IPO DateWithdrawn
CEODonald A. Deieso, Ph.D.
Stock ExchangeNASDAQ
Ticker SymbolWCGC
Full Company Profile

Financial Performance

Financial Statements


WCG Clinical IPO Registration Document (S-1)

WCG Clinical Inc, a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, filed for an initial public offering (IPO) in the United States on Thursday and revealed a jump...

3 months ago - Reuters

WCG Clinical IPO Registration Document (S-1)

WCG Clinical, Inc. has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC